Republican Governor Mike DeWine of Ohio on Thursday blocked the plans of the Ohio Board of Pharmacy and the State Medical Board to ban the use of hydroxychloroquine as a treatment of COVID-19.
DeWine tweeted, “I agree with the statement from Dr. Steven Hahn, Commissioner of the Food and Drug Administration, that the decision about prescribing hydroxychloroquine to treat COVID-19 should be between a doctor and a patient. The Board of Pharmacy and the State Medical Board of Ohio should revisit the issue, listen to the best medical science, and open the process up for comment and testimony from experts. Therefore, I am asking the @OhioRxBoard to halt their new rule prohibiting the selling or dispensing of hydroxychloroquine or chloroquine for the treatment or prevention of COVID-19.”
On Wednesday, the Ohio Department of Health (ODH) revealed that the Ohio Board of Pharmacy has come out with a ruling that prohibits the selling or dispensing of hydroxychloroquine and chloroquine to treat coronavirus.
ODH spokeswoman Melanie Amato explained that hydroxychloroquine was not an effective treatment for the coronavirus.
The new Board of Pharmacy rule reads, “On July 15, the FDA has revoked the emergency authorization to use hydroxychloroquine and chloroquine to treat COVID-19 in certain hospitalized patients when a clinical trial is unavailable or participation is not feasible. The agency made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery. This outcome was consistent with other new data, including those showing the suggested dosing for these medicines is unlikely to kill or inhibit the virus that causes COVID-19.”